While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 ...

"The settlement relates to alleged conduct at Biohaven before Pfizer’s acquisition of the company in October 2022 and does not include any admission of liability or wrongdoing. We are pleased to put ...

Finally, UBS Group lowered their price objective on shares of Pfizer from $31.00 to $29.00 and set a “neutral” rating for the company in a research report on Wednesday, January 8th.

Analysts expect Pfizer to post earnings of $0.48 per share and revenue of $17,264,454.90 billion for the quarter. Persons interested in participating in the company’s earnings conference call ...

"We can do these things because we have made it our business to attain scientific and technical knowledge through research, to increase our ability to produce, and to build Pfizer into a world-wide ...

MSFT, ORCL, and CRM lead the 9 biggest software companies list Nathan Reiff has been writing expert articles and news about financial topics such as investing and trading, cryptocurrency ...

NEW YORK (Reuters) - Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks so doctors would prescribe the ...

NEW YORK (Reuters) - Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks so doctors would prescribe the ...

It is officially the week of one of Cape Town’s biggest art, fashion, lifestyle and entertainment events in the highly coveted 2025 World Sports Betting Cape Town MET, and everyone is immersed in the ...

The South African Weather Service said Cape Town residents must brace themselves for an increase in temperatures A heatwave is expected to sweep through the Western Cape, and Cape Town will be hit The ...

The stock's valuation signals that the market is misjudging Pfizer. The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light. The company's ...